Janus Henderson Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.05B	Buy	2,018,647 +433,804	+27%	+$207M	0.5%	35
2025 Q4	$918M	Sell	1,584,843 -257,847	-14%	-$132M	0.41%	47
2025 Q3	$845M	Sell	1,842,690 -349,063	-16%	-$130M	0.39%	48
2025 Q2	$663M	Sell	2,191,753 -14,096	-0.6%	-$4.2M	0.33%	65
2025 Q1	$723M	Sell	2,205,849 -2,545	-0.1%	-$836K	0.4%	48
2024 Q4	$681M	Sell	2,208,394 -269,766	-11%	-$75.9M	0.35%	59
2024 Q3	$526M	Sell	2,478,160 -7,591	-0.3%	-$1.94M	0.27%	89
2024 Q2	$696M	Sell	2,485,751 -115,531	-4%	-$27.5M	0.37%	55
2024 Q1	$695M	Sell	2,601,282 -300,768	-10%	-$70.9M	0.38%	50
2023 Q4	$672M	Sell	2,902,050 -140,611	-5%	-$24.6M	0.4%	52
2023 Q3	$444M	Buy	3,042,661 +1,558,535	+105%	+$293M	0.29%	90
2023 Q2	$343M	Buy	1,484,126 +1,108,452	+295%	+$300M	0.21%	118
2023 Q1	$91M	Buy	375,674 +193,026	+106%	+$52.6M	0.06%	267
2022 Q4	$53M	Buy	182,648 +9,882	+6%	+$966K	0.04%	357
2022 Q3	$11.2M	Buy	+172,766	New	+$12M	﹤0.01%	802
2018 Q4	–	Sell	-1,343	Closed	-$288K	–	1397
2018 Q3	$288K	Buy	1,343 +454	+51%	+$114K	﹤0.01%	1387
2018 Q2	$249K	Buy	+889	New	+$156K	﹤0.01%	1348